TrueMark Investments’s Amgen AMGN Stock Holding History

TrueMark Investments’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-973	Closed	-$318K	–	170
2025 Q4	$318K	Buy	+973	New	+$309K	0.06%	177
2025 Q2	–	Sell	-1,328	Closed	-$414K	–	144
2025 Q1	$414K	Buy	+1,328	New	+$392K	0.11%	118

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

TrueMark Investments's AMGN Position: Q1 2026 in Review

TrueMark Investments sold out of Amgen (AMGN) in Q1 2026, closing a stake of 973 shares — an estimated $318K sold.

TrueMark Investments first reported a position in AMGN in Q1 2025 and held it in 2 quarters. The position peaked at $414K in Q1 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

TrueMark Investments reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
TrueMark Investments sold 973 Amgen shares in Q1 2026, an estimated $318K.
TrueMark Investments first reported a position in Amgen in Q1 2025 and held it in 2 quarters.
TrueMark Investments's Amgen position peaked at $414K in Q1 2025.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on TrueMark Investments's 13F filing for Q1 2026, filed 20 Apr 2026.